About The Study: In this phase 2 prospective validating paired cohort study, fluorine-18 PSMA-1007 PET/computed tomography was superior to magnetic resonance imaging (MRI) for the locoregional staging of prostate cancer. These findings support PSMA PET in the preoperative workflow of intermediate-risk and high-risk tumors.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.